← FDA Drug Approvals (Drugs@FDA)
DEFERASIROX
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2019-11-20
Drug application
- FDA Application #
ANDA209878- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEFERASIROX
- Generic name
- DEFERASIROX
- Active ingredients
- DEFERASIROX
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN
- Manufacturer
- Dr. Reddy's Laboratories Inc
- First approval
- 2019-11-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown